Biofilm modifiers: The disparity in paradigm of oral biofilm ecosystem.


Journal

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 14 03 2023
revised: 19 05 2023
accepted: 29 05 2023
medline: 22 6 2023
pubmed: 4 6 2023
entrez: 3 6 2023
Statut: ppublish

Résumé

A biofilm is a population of sessile microorganisms that has a distinct organized structure and characteristics like channels and projections. Good oral hygiene and reduction in the prevalence of periodontal diseases arise from minimal biofilm accumulation in the mouth, however, studies focusing on modifying the ecology of oral biofilms have not yet been consistently effective. The self-produced matrix of extracellular polymeric substances and greater antibiotic resistance make it difficult to target and eliminate biofilm infections, which lead to serious clinical consequences that are often lethal. Therefore, a better understanding is required to target and modify the ecology of biofilms in order to eradicate the infection, not only in instances of oral disorders but also in terms of nosocomial infections. The review focuses on several biofilm ecology modifiers to prevent biofilm infections, as well as the involvement of biofilm in antibiotic resistance, implants or in-dwelling device contamination, dental caries, and other periodontal disorders. It also discusses recent advances in nanotechnology that may lead to novel strategies for preventing and treating infections caused by biofilms as well as a novel outlook to infection control.

Identifiants

pubmed: 37269809
pii: S0753-3322(23)00756-4
doi: 10.1016/j.biopha.2023.114966
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

114966

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Antarikshya Das (A)

KIIT School of Dental Sciences, KIIT University, Bhubaneswar 751024, Odisha, India.

Swadheena Patro (S)

KIIT School of Dental Sciences, KIIT University, Bhubaneswar 751024, Odisha, India. Electronic address: drswadheenapatro@gmail.com.

Faizan Zarreen Simnani (FZ)

KIIT School of Biotechnology, KIIT University, Bhubaneswar 751024, Odisha, India.

Dibyangshee Singh (D)

KIIT School of Biotechnology, KIIT University, Bhubaneswar 751024, Odisha, India.

Adrija Sinha (A)

KIIT School of Biotechnology, KIIT University, Bhubaneswar 751024, Odisha, India.

Khushbu Kumari (K)

KIIT School of Dental Sciences, KIIT University, Bhubaneswar 751024, Odisha, India.

Patnala Vedika Rao (PV)

KIIT School of Medical Sciences, KIIT University, Bhubaneswar 751024, Odisha, India.

Sarita Singh (S)

BVG Life Sciences Limited, Sagar Complex, Old Pune-Mumbai Road, Chinchwad, Pune 411034, India.

Nagendra Kumar Kaushik (NK)

Plasma Bioscience Research Center, Department of Electrical and Biological Physics, Kwangwoon University, 01897 Seoul, Republic of Korea. Electronic address: kaushik.nagendra@kw.ac.kr.

Pritam Kumar Panda (PK)

Condensed Matter Theory Group, Materials Theory Division, Department of Physics and Astronomy, Uppsala University, Box 516, SE-751 20 Uppsala, Sweden. Electronic address: pritam.panda@physics.uu.se.

Mrutyunjay Suar (M)

KIIT School of Dental Sciences, KIIT University, Bhubaneswar 751024, Odisha, India. Electronic address: msuar@kiitbiotech.ac.in.

Suresh K Verma (SK)

KIIT School of Dental Sciences, KIIT University, Bhubaneswar 751024, Odisha, India. Electronic address: sureshverma22@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH